The JSE was firmer on Tuesday midday, as hopes about a successful early-stage trial of a coronavirus vaccine lifted investor sentiment, and prospects of more stimulus from major global economies added to global recovery optimism.

US biotechnology company Moderna has reported that a phase-1 trial of its coronavirus vaccine has shown promising results, showing signs that it can create an immune-system response to fend off the new coronavirus...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.